Efficacy and Safety of Adherence to dl-3-n-Butylphthalide Treatment in Patients With Non-disabling Minor Stroke and TIA—Analysis From a Nationwide, Multicenter Registry

Background: Dl-3-n-Butylphthalide (NBP) has the potential to improve clinical outcomes in acute ischemic stroke patients by improving collateral circulation. We aimed to evaluate the efficacy and safety of NBP in patients with non-disabling minor ischemic stroke and transient ischemic attack (TIA)....

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Zefeng, Zhao, Yin, Yang, Wanyong, He, Shenwen, Ding, Yan, Xu, Anding
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492907/
https://www.ncbi.nlm.nih.gov/pubmed/34630292
http://dx.doi.org/10.3389/fneur.2021.720664

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492907/
https://www.ncbi.nlm.nih.gov/pubmed/34630292
http://dx.doi.org/10.3389/fneur.2021.720664

Ejemplares similares